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SEL PEMBEKU DARIPADA PLASMA YANG DIPERKAYA DENGAN SEL 
PEMBEKU DAN MESIN AFERESIS: PARAMETER BIOKIMIA, FUNGSI 
ASAI DAN HASIL KLINIKAL 
 
ABSTRAK 
 
Fungsi sel pembeku ialah untuk membentuk mekanikal plak untuk mengelak  
pendarahan akibat salur vaskular yang cedera hasil daripada tindakbalas normal 
homeostatis. Secara amnya, pemindahan sel pembeku boleh mengurangkan risiko 
kematian akibat pendarahan. Disamping kondisi pesakit, kejayaan rawatan adalah 
bergantung kepada kualiti sel pembeku yang dipindahkan. Membekalkan pesakit 
dengan sel pembeku yang befungsi secara optimum adalah menjadi kebimbangan 
kepada Pusat Darah Negara (PDN). Pada masa ini di PDN, sel pembeku yang 
disediakan oleh mesin apheresis dan kaedah manual digunakan dengan meluas secara 
klinikal kerana permintaan sel pembeku yang semakin meningkat di Malaysia. 
Walau bagaimanapun, kualiti sel pembeku yang dihasilkan melalui kaedah manual 
dan melalui mesin apheresis mestilah disiasat dan dibandingkan kualitinya. Kualiti 
sel pembeku yang dihasilkan dipengaruhi oleh kaedah penyediaan, jenis bekas 
penyimpanan, larutan penyimpanan dan kondisi penyimpanan. Kajian ini dijalankan 
untuk membandingkan kualiti sel pembeku yang disediakan melalui dua kaedah 
penyediaan sel pembeku yang berbeza; kaedah manual berbanding kaedah mesin 
automasi apheresis; “W”, “X”, “Y” and “Z” dengan menentukan  pH, sterility, 
bacaan sel pembeku, tahap sitokin dan pengaktifan pembeku dan setrusnya mengkaji 
kesan pemindahan sel pembeku seteleh dipindahkan kepada pesakit. Kualiti sel 
pembeku yang diperolehi boleh dipengaruhi oleh beberapa keadaan, seperti 
pengemparan pada kelajuan yang tinggi, pendedahan kepada permukaan tiruan, 
xviii 
 
penyimpanan dalam pelbagai jenis beg dan kaedah penyediaan sel pembeku yang 
berbeza yang mungkin bukan sahaja mempengaruhi tahap lesi penyimpanan sel 
pembeku tetapi juga boleh menyumbang kepada kurangnya keberkesanan dan tindak 
balas transfusi klinikal. Pengaktifan sel pembeku boleh menyumbang dilesi 
penyimpanan sel pembeku. Akibat lesi, sel pembeku akan  memberikan kesan pada 
struktur dan fungsinya dalam proses hemostasis biasa.  
Parameter biokimia yang diuji termasuk pngiraan sel pembeku, pH, steril dan tahap 
cytokines (RANTES dan TGF-β1) menggunakan ELISA , fungsi asai yang dikaji 
ialah pengaktifan sel pembeku (CD62) menggunakan flow sitometer dan mengkaji 
kesan klinikal pencapaian in vivo selepas pemindahan sel pembeku ke dalam aliran 
darah pesakit melalui bacaan sel pembeku pada pra dan pos pemindahan.  Kajian ini 
menunjukkan tiada perbezaan yang signifikan diperhatikan pada tahap sitokin 
(RANTES dan TGF-β1), pengiraan sel pembeku dan steriliti sel pembeku dalam 
kedua-dua kaedah penyediaan. Tiada perbezaan yang signifikan dalam pengaktifan 
sel pembeku antara kedua-dua kaedah, manual dan mesin apheresis. Kedua-dua 
kaedah menunjukkan peningkatan pengaktifan sel pembeku dari hari ke sehari 
semasa dalam penyimpanan. Namun kajian ini menunjukkan bahawa sel pembeku 
yang disediakan oleh mesin apheresis “Y” dan “Z” menunjukkan sedikit  kelebihan 
iaitu dengan pengaktifan sel pembekunya yang paling minima. Mesin apheresis 
paling tinggi sel pembeku teraktif ialah mesin “X”. Berdasarkan keputusan kajian ini, 
mesin apheresis yang menghasilkan sel pembeku teraktif yang paling minima ialah 
mesin “Y”dan“Z”. Dengan itu adalah disyorkan kedua-dua mesin tersebut 
digunapakai sebagai kaedah penyediaan sel pmbeku mengatasi kaedah-kaedah yang 
lain di PDN, Malaysia.   
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PLATELET CONCENTRATES FROM PLATELET-RICH PLASMA AND 
APHERESIS MACHINES: BIOCHEMICAL PARAMETERS, FUNCTIONAL 
ASSAYS AND CLINICAL OUTCOMES 
 
ABSTRACT 
 
The function of platelets is to form a mechanical plug to seal the site of vascular 
injury during hemostatic. Generally, platelet transfusion can reduce the risk of 
mortality. Aside from the general condition of patients, the quality of platelets to be 
transfused is highly important for a successful treatment. Providing patients with 
optimally functioning platelet concentrates (PCs) is the major concern of National 
Blood Center (NBC). For more than three decades, the manual method of platelet 
preparation has been the standard procedure in the National Blood Center (NBC) of 
Malaysia. However, the quality of PCs prepared through the manual and apheresis 
methods has yet to be investigated and compared. The quality of PCs is affected by 
preparation methods, types of storage bags, storage solution and storage conditions.  
This study aims to determine the quality and outcomes of the PCs obtained using the 
manual method and the automated apheresis machines; “W”, “X”, “Y” and “Z” by 
detecting the pH, sterility, platelet count, cytokine and platelet activation levels as 
well as determining the efficacy of platelet after being transfused to the patients. The 
quality of platelet concentrates obtained is affected by several factors such as high 
centrifugation forces, exposure to artificial surfaces, storage in different types of bags 
and different platelet preparation methods. These factors may affect the extent of 
platelet storage lesions and contribute to the poor clinical effectiveness and 
transfusion reactions of platelet concentrates. Platelet activation in PCs may 
contribute to platelet storage lesions. These lesions influence the structures and 
xx 
 
functions of platelets during normal hemostatic processes. The biochemical 
parameters that were tested included platelet count, pH, sterility and cytokine levels 
(RANTES and TGF-β1) using ELISA. The functional assay that was analyzed 
included platelet activation (CD62) using flow cytometry. The outcomes of platelet 
transfusion were also evaluated through the pre- and post-platelet counts. Any 
adverse effect of platelet transfusion on the patients was also determined. This study 
showed that there was no significant differences in cytokine levels (RANTES and 
TGF-β1) found between the PCs obtained using manual methods and PCs obtained 
from different types of apheresis machines. No significant difference was observed 
in PCs obtained using manual method and PCs obtained from different types of 
apheresis machines in platelet activation level. Significant differences in platelet 
activation were noted between groups across time in both methods of platelet 
preparation. However, this study shows that the PCs with the least activated platelets 
were those collected using machines “Y” and “Z”, although there was no significant 
differences were observed. Among the PCs obtained using the other apheresis 
machines, those obtained using machine “X” showed the highest platelet activation. 
Based on the results of this study, machines that produced the least activated platelets 
were machines “Y” and “Z”. Hence, these two machines, was suggested serving as 
compared to the others methods, as the standard of platelet collection in the NBC of 
Malaysia. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Back ground of the study 
 
The global demand for platelet transfusion is continuously increasing because of 
therapies that use platelet concentrates (PCs). The best and effective treatment for 
patients with bleeding problems and other diseases, such as severe 
thrombocytopenia, DIVC (disseminated intravascular coagulation), acute leukemia 
and aplastic anemia is transfusion. Generally, platelet transfusion can reduce the risk 
of mortality due to hemorrhage. 
The function of platelets is to form a mechanical plug to seal the site of vascular 
injury during homeostasis. Platelets promote the regeneration of injured tissues in 
surgical, oncological and transplant patients. Patients with low platelet counts 
(5,000/µL to 10,000/µL) use PCs as prophylaxis. Patients with thrombocytopenia 
caused by diseases or chemotherapy need high-quality platelets to overcome their 
haemostatic problems. Therefore, the platelets to be transfused must possess 
effective haemostatic functions. Aside from the general condition of patients, the 
quality of platelets to be transfused is highly important for successful treatment. 
The manual method for platelet collection is through manual centrifugation of whole 
blood and obtaining platelet-rich plasma (PRP). This method involves the separation 
of platelets from multiple bags of whole blood collected from several donors. Several 
units of PCs are pooled because a single unit of donated whole blood contains only a 
small amount of PCs.  
 
2 
 
This manual method involves several processing steps that may cause platelet surface 
changes (morphological changes), thereby affecting the quality of platelet product. 
The risk of alloimmunization and virus transmission to a recipient is higher in single 
unit of PCs because of the number of blood donation from several donors. Moreover, 
the manual method is more time consuming and labor intensive compared with the  
automated apheresis machines. Automated apheresis machines are widely used not 
only because of the lower risk of alloimmunization and viruses transmission but 
these machines can extract as many platelets as possible from a single donation (1). 
Hence, the quality and quantity of platelets yield are improved and the time required 
to prepare the PCs is reduced. All the procedures for platelet preparation were under 
standardized protocols. The equipment, materials, reagents and staff involved in the 
preparation of PCs using apheresis method meet the quality system requirements 
based on international guidelines from American Association of Blood Banks, 
(AABB). However, the quality of PCs prepared via the automated apheresis method 
should be considered and compared with that of PCs prepared using the manual 
method. 
The quality of the PCs obtained from the apheresis method can be influenced by 
several factors, such as high centrifugation forces, exposure to artificial surfaces, 
storage in different types of bags and different platelet preparation methods. These 
factors may influence the extent of platelet storage lesions and contribute to the poor 
clinical effectiveness and transfusion reactions of PCs (2–3). PCs undergo a number 
of changes and alteration during collection, processing and storage, which are 
classified as platelet storage lesions (4, 5). It has been demonstrated that platelet 
activation plays a major role in the generation of platelet storage lesions in PCs. 
3 
 
These lesions affect the structures and functions of platelets during normal 
haemostatic processes, leading to loss of integrity of platelet function, changes in 
aggregation and release, rearrangement of platelet cytoskeleton, exposure of 
phosphatidyl serine on the outer membrane surface and microvesiculation (5,6).  
Alterations in shear stress and the biocompatibility of platelet surfaces may provide 
variable platelet activation, thereby affecting the quality of PCs (7–10). 
Studies showed that a reduced response to agonist stimulation (8–11), low survival 
of transfused platelets and prolonged in vitro bleeding time are associated with high 
degree of platelet activation in PCs (12, 13).   
The initial lesion involved during the isolation process is essential for the quality of 
PCs during storage. It is proposed that deterioration of PCs during storage might be 
related to platelet activation occurring during preparation (14–18). 
It has been shown that platelet activation leads to the degranulation and release of 
platelet-derived cytokines include CCL5 or Regulated upon Activation, Normal T-
cell Expressed and presumably Secreted (RANTES). This cytokine has been 
suggested to be implicated in non-hemolytic transfusion reactions together with 
Transforming Growth Factor-ß1, (TGF-ß1) (19–22). Incidences of non-hemolytic 
transfusion reaction are recognized as adverse events after PCs transfusion.  
Common reactions usually involve chills, nausea and fever, whereas more serious 
reactions include anaphylaxis and TRALI (transfusion-related acute lung injury). 
Non-hemolytic transfusion reactions following platelet transfusion does not involve 
immune-mediated events but appear to be caused by cytokines (22–25) and 
administration of plasma containing large amounts of cytokines (26).  
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Platelet-derived cytokines may contribute towards the events of non-hemolytic 
transfusion reactions following high levels of RANTES in PCs that can cause 
allergic reaction (27). Studies have shown that a large part of febrile transfusion 
reactions results from transfusion of stored PCs which contains higher levels of 
cytokines and not from antigen-antibody reactions (28). The release of platelet 
chemokines into the suspension medium of stored PCs may be mediated by active 
secretion due to platelet activation during storage or it may be related to the lyses of 
some platelets. Increased supernatant levels of these cytokines possibly indicate 
platelet activation or destruction. Although very few data are available on the in vivo 
effects of transfused cytokines, it has been suggested that the high incidence of 
adverse reactions is often observed after platelet transfusion (29). 
For more than three decades, the manual method of platelet preparation has been the 
standard procedure in the National Blood Center (NBC) of Malaysia. In the 1980s, 
automated apheresis machines were introduced. The use of automated apheresis 
machines can reduce the risk of alloimmunization and virus transmission to patients 
afforded by reduced donor exposure (1). 
Since then, manual and apheresis methods have been the standard of platelet 
component preparation in the NBC of Malaysia. Currently, PCs prepared via the 
apheresis and manual methods in NBC are in widespread clinical use because of the 
continuously increasing demand for PCs in Malaysia. Providing patients with 
optimally functioning PCs is the major concern of NBC. However, the quality of PCs 
prepared through the manual and apheresis methods has yet to be investigated and 
compared. The quality of PCs is affected by preparation methods, storage bags types, 
storage solution and storage conditions. 
5 
 
The proportion of activated platelets has been suggested to be a predictor of platelet 
quality. Previous studies also have suggested that cytokines, such as IL-1, IL-6, IL-8, 
TNF-α (tumor necrosis factor-α) and RANTES, which are released by leucocytes 
and/or other cell types during platelet component storage, may play causative roles in 
the origin of adverse reactions in some recipients (22–27,  29). The quality of PCs 
can be evaluated in vitro by analyzing the following parameters: pH, bacterial 
contamination, platelet activation, cytokine level, white blood cell count, platelet 
swirling, clotting time and coagulum elasticity. 
Platelet quality is related to the preparation methods for PCs. The quality of platelets 
to be transfused to patients is the priority of the NBC. Accordingly, this study 
compares the quality of the platelet product obtained using the manual method and 
the automated apheresis machines by detecting the platelet activation and cytokine 
levels after PCs preparations. The efficacy of the PCs in vivo was evaluated by 
detecting the pre- and post-platelet counts after PCs transfusion. Thus so far, the 
efficacy of PCs prepared using the manual method and the apheresis method has 
never been officially reported in whole blood center of Malaysia.  
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1.2 Objectives 
 
1.2.1 General objective 
This research aim to compare the quality of PCs and outcome of the platelet count 
in patient after being transfused with the PCs obtained using the manual method 
and PCs obtained from four types of automated apheresis machines (“W”, “X”, “Y” 
and “Z”), by detecting the cytokines levels and platelet activation after platelet 
preparation. 
 
1.2.2 Specific objectives 
1. To determine and compare platelet activation in PCs prepared using the 
manual method and four types of apheresis machines through flow cytometry. 
2. To determine the levels of cytokines (RANTES) in PCs prepared using the 
manual method and four types of apheresis machines using enzyme-linked 
immunosorbent assay (ELISA).  
3. To determine the levels of cytokines (TGF-β1) in PCs prepared using the 
manual method and four types of apheresis machines using enzyme-linked 
immunosorbent assay (ELISA).  
4. To determine the pre- and post-transfusion platelet counts in patients 
transfused with PCs prepared using the apheresis methods from patient‟s record. 
5. To determine the adverse effects of transfusion in patients as a result of 
apheresis platelet transfusion from patient‟s record. 
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1.3 Significance of the study 
 
Methods used for the preparation of PCs are important in influencing the platelet  
activation process and cytokine levels in PCs. This study embarked on finding the  
best method to achieve high-quality PCs and improve the function of platelets in 
vivo, potentially leading to the improved clinical effectiveness of platelet transfusion 
by the NBC of Malaysia as well as the whole blood center in Malaysia. 
 
1.4 Hypothesis 
 
1.4.1 Null Hypothesis (Ho) 
Ho:  There is no differences exist in the quality of PCs prepared using the manual 
method and different types of apheresis machines. 
 
1.4.2 Study Hypothesis (Ha)  
H1: There is differences exist in the quality of PCs prepared using the manual method 
and different types of apheresis machines. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Platelets 
 
2.1.1 Platelet production 
Platelets bud off from large bone marrow cells called megakaryocytes through 
cytoplasm fragmentation (Fig. 2.1.1). Megakaryocytes are derived from hemopoietic 
stem cells, which are stimulated to differentiate to mature megakaryocytes. 
Megakaryoblasts are the precursors of megakaryocytes; they arise through 
differentiation from hemopoietic stem cells.  
Megakaryocytes mature via endomitotic synchronous replication, enlarging the 
cytoplasmic volume as the number of nuclear lobes increase in multiples of two (30).  
Thrombopoietin is a humoral agent that controls platelet production. The interval 
time for human stem cell differentiation to produce platelets is approximately 10 
days. After their release from the bone marrow, young platelets are trapped in the 
spleen for up 36 hours before entering the blood circulation. The normal platelet 
lifespan is approximately 10 days in the blood and the normal platelet count is 
approximately 250 × 10
9
/L (range 150–400 × 109/L). 
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Figure 2.1.1 Platelets budding off from a megakaryocyte. 
Megakaryocyte with lobulated nucleus (a) and platelets (b). 
(Adopted from Ann Bell, The morphology of Human Blood Cells, 2005) 
 
 
 
 
 
 
 
a 
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2.1.2 Platelet structure 
Platelets are small and discoid enucleated blood cells with a diameter of 3.0 × 
0.5 µm. Platelets play important roles in hemostasis and thrombosis. The small size 
and shape of platelets allow them to be pushed to the edge of vessels, placing them 
next to endothelial cells and enabling them to respond to vascular damage. During 
adhesion and aggregation, the GP glycoprotein of the surface coat plays an important 
role in the formation of plugs during hemostasis. Platelets contain three main types 
of storage granules: dense-granules, -granules and lysosomes. Each type rapidly 
releases its contents upon activation (30). The ultra structure of platelets is shown in 
Fig. 2.1.2 (a). 
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Figure 2.1.2 (a) Ultrastucture of platelets. ADP, adenosine diphosphate; PDGF, 
platelet-derived growth factor; PF, platelet factor; and vWF, von Williebrand 
factor. 
(Adopted from A.V.Hoffbrand, Essential Hematology, 1993) 
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Although platelets are fragments of cells, they contain most cellular organelles, 
including microtubules, mitochondria, peroxisomes and specific granules.  Resting 
platelets are discoid and have smooth surfaces, whereas activated platelets are 
spherical in shape with pseudopod extrusion [Fig. 2.1.2 (b)]. Platelets are surrounded 
by a bilamellar plasma membrane that extends into the channels of the surface 
connected to the canalicular system. Through this surface membrane, intrinsic GPs 
extrude to serve various functions in homeostasis (30). Platelets are enriched in 
signaling proteins and surface receptors, enabling them to respond immediately and 
effectively during homeostasis.  
The outer layer of a platelet is coated with numerous GPs, whose surfaces contain 
several receptors called platelet-independent surface markers. These markers take 
part in binding with various aggregating and adhesive agents in normal platelet 
adhesion or aggregation, leading to the formation of platelet plugs during 
homeostasis. Platelet membrane GPs serve various functions, including receptor 
binding of ligands necessary for the adhesion of platelets to leucocytes, fibrin, 
endothelial cells and extracellular matrix (31).  
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(i)                                                            (ii) 
 
Figure 2.1.2 (b) Electron micrographs of resting (i) and activated (ii) platelets. 
Resting platelets are smooth and discoid (left). Activated platelets have an 
irregular shape with several protruding pseudopodia (right). 
Source: http://www.platelet-research.org/l/function_hemo.htm## 
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The expression of GPs on the surface of platelets reflects the activation status and the 
extent of secretion. The surface expression of p-selectin (CD62P) can be assessed 
when platelets become activated, reflecting the translocation of α-granule membrane 
protein (α-GMP) on the platelet surface and the conformational change of the GPIIb-
IIIa complex (32). The presence of GP platelet membrane on the platelet surface has 
become useful in fundamental research towards the development of new drugs and 
anti-thrombin. Previous studies reported that thrombus or hemostatic plugs are 
poorly formed or absent in patients with congenital defect of GPIb-IX (Bernard-
Soulier syndrome) or GPIIb-IIIa (Glanzman thrombasthenia) (33 and 34). 
 
2.1.3 Platelet functions  
Platelets are essential in hemostasis to prevent bleeding, secrete growth factors to 
stimulate healing after injury and maintain normal vascular integrity. In the absence 
of platelets, spontaneous leakage of blood may occur through small vessels (30). 
Platelet functions fall into four categories: adhesion, aggregation, secretion and 
activation. These processes occur on the extracellular matrix components of the 
exposed sub endothelium of injured vessels (35) as represented in Fig. 2.1.3. 
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Figure 2.1.3 Simplified diagram of platelet adhesion, activation, aggregation, 
and secretion in primary hemostasis. 
Source: http://www.strokecenter,org/professionals/brain-anatomy/platelet-
activation 
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2.1.4 Platelet activation 
Platelet activation is a process in which platelets change shape, aggregate, adhere to 
vascular walls and secrete cytokines during homeostasis. Platelet activation involves 
a series of changes in platelet metabolic biochemistry, morphology and functions. 
This process is controlled by complex networks of activating and inhibiting 
intracellular signaling pathways. Platelet activation occurs in both in vivo and in vitro 
stages. The extent of platelet activation in vitro depends on various circumstances, 
such as the PCs preparation method (2), storage medium of PCs (i.e., in plasma or in 
additive solution) and duration of storage.  
P-selectin (CD62), a protein stored in the alpha granule membrane protein (α-GMP) 
of activated platelets, may be used as an index to determine the activation status of 
PCs in vitro. When platelets are activated, platelet surface molecules will changes, 
which can be detected by flow cytometry using fluorescent-conjugated antibodies to 
fibrinogen, p-selectin (CD62P), GPIIb-IIIa (CD41), GPIb alpha (CD42b), and GPV 
(CD42d) (32, 40). These seen as a useful approach to determine the platelet quality 
in platelets concentrate in various platelet preparation method. 
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2.1.5 Platelet storage lesions 
Platelet storage lesions are characterized by the following phenomena. First is the 
change in platelet shape from discoid to spherical. Second is the generation of lactic 
acid from glycolysis, with an associated decrease in pH. Third is the release of 
cytoplasmic and granule contents. Fourth is the decrease in various in vitro 
measurements of platelet function, particularly osmotic challenge. Fifth is the 
adenosine di-phosphate (ADP) induced change in shape. These lesions may have an 
impact on platelet viability and haemostatic function. The storage lesion leads to 
structural, biochemical and functional alterations that are hallmarks of the process 
of activation, a multifaceted phenomenon in which substances are released from 
granules, membrane constituents are modified and functional responses are altered 
(43). Last is the reduction of in vivo recovery and survival (41 and 42). Platelets 
become spherical in shape, reducing their viability and ability to perform well in 
homeostasis once activated. Changes in platelet function and structure in PCs can 
be explained in terms of sequelae of activation (11). Platelet activation plays major 
role in storage lesions in PCs (12).  
Platelet activation can be detected by flow cytometry. As shown in Fig. 2.1.5 (a, b 
and c), platelet activation has three phases: activation of GPIIb/IIIa, release reaction 
with the exposure of p-selectin (CD62p), and platelet procoagulant activity (44).   
Tomer et al., revealed that the first event that can be detected in this process is the 
activation of the membrane integrin 23 (GPIIb/IIIa, CD41a).  
 
 
18 
 
The activated GPIIb/IIIa complex creates a functional receptor for fibrinogen, which 
provides a link between adjacent platelets to form aggregates. The activation of this 
receptor can be detected by specific monoclonal antibodies such as PAC-1 and anti- 
ligand-induced binding site 1 (anti-LIBS1). The former antibody competes with 
fibrinogen, whereas the latter antibody interacts with a ligand-induced binding site 
and a receptor-induced binding site (RIBS) on the fibrinogen molecule [Fig 2.1.5 
(a)]. 
 
 
Figure 2.1.5 (a) Activation of GPIIb/IIIa. The first event is the activation of the 
membrane integrin 23 (GPIIb/IIIa, CD41a). 
(Adopted from Tomer et al. 2004). 
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The second event in platelet activation process is the secretion of active mediators, 
such as ADP, serotonin, and thromboxane, resulting in further recruitment of 
platelets at the injury site. The secretion process is accompanied by the translocation 
to the outer membrane of the -GMP p-selectin (CD62P), which can be detected by 
a specific monoclonal antibody [Fig. 2.1.5 (b)]. 
 
 
Figure 2.1.5 (b) Release reactions with the exposure of p-selectin. The second 
event is the secretion of active mediators such as ADP, serotonin, and 
thromboxane. 
(Adopted from Tomer et al. 2004). 
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The final event in the platelet activation process is the expression of procoagulant 
activity via the exposure of membrane anionic phospholipids. The exposed 
determinants serve as binding sites for the prothrombinase complex (including 
prothrombin and coagulation factors Xa and Va). This assembly markedly enhances 
the generation of thrombin, which is a key factor in hemostasis. The membrane 
procoagulant activity can be detected by the binding of the placental anticoagulant 
protein annexin V to the anionic phospholipids or of monoclonal antibodies directed 
against factor Xa or Va, such as V261, on the platelet surface [Fig. 2.1.5 (c)]. 
 
 
Figure 2.1.5 (c) Platelet procoagulant activities. The final event is the expression 
of procoagulant activity via the exposure of membrane anionic phospholipids. 
(Adopted from Tomer et al. 2004). 
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2.2 Flow cytometry   
 
2.2.1 Introduction 
Flow cytometry is a valuable tool in medical research because of its ability and 
competency to analyze several thousand particles with the multiple physical 
characteristics of a single cell as they flow in a fluid stream through a beam of light 
in a short period without physical damage to the cells. Flow cytometry is also a 
reliable and useful method for the detection of platelet activation markers [Figure 
2.2.1 (a)]. Flow cytometric characterization of platelet membrane glycoprotein (GP) 
expression and procoagulant surface is a sensitive technique for the identification of 
platelet activation in PCs (53). Monoclonal antibodies against platelet surface GP is 
use to identify activated platelets and the markers as well as platelet interactions with 
other cell were detected through flow cytometry. Activated platelets can be reliably 
detected in whole blood using activation-dependent monoclonal antibodies. Flow 
cytometry is time-consuming and expensive but it‟s a valuable research tool (35). 
Flow cytometry, is a useful technique for the assessment of the degree of platelet  
activation and the efficacy of antiplatelet therapy in clinical disorders (38 and 54). 
Moreover, flow cytometry is a useful tool for studying the mechanisms that induce in 
vivo and in vitro platelet activation and for detecting ongoing in vivo prothrombotic 
activity (28).  
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Figure 2.2.1 (a) Becton Dickinson (BD) FACSCalibur. 
 Flow cytometry is a technology that simultaneously measures and then analyzes 
multiple physical characteristics of single particles (cells or beads), as they flow 
in a fluid stream through a beam of light. 
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Flow cytometers consist of three important components: fluid system, an optical 
system, and an electronic system. These three systems work together to give 
information on relative cell size, internal complexity and fluorescence [Fig. 2.2.1(b)]. 
All flow cytometers consist of a fluidics system to introduce the cells for 
interrogation. The role of the fluidics system is to carry the suspended cells out of the 
sample test tube and into the sensing region of the flow cell. Cells are carried in the 
sample core stream in single file and measured individually. The function of an 
optical system is to collects light signals generated as cells pass through the laser and 
the role of an electronic system is to converts light signals to proportional electronic 
signals that are then digitized for computer analysis (45). 
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Figure 2.2.1(b) Diagram showing the fluidic, optical and electronic systems of  
a flow cytometer. These three systems work together to give information on 
relative cell size, internal complexity and fluorescence 
(Adopted from Introduction to Flow cytometry, Becton Dickinson, BD 2008) 
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